bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer.

Scopa, C D

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. [electronic resource] - Applied immunohistochemistry & molecular morphology : AIMM Dec 2001 - 329-34 p. digital

Publication Type: Journal Article

1541-2016

10.1097/00129039-200112000-00007 doi


Adenocarcinoma--diagnosis
Biomarkers--analysis
Combined Modality Therapy
Humans
Immunohistochemistry
Prognosis
Proto-Oncogene Proteins--analysis
Proto-Oncogene Proteins c-bcl-2--analysis
Radiotherapy, Adjuvant--standards
Rectal Neoplasms--diagnosis
Treatment Failure
bcl-2-Associated X Protein